CHI3L1 and pancreatic neoplasm: In line with this data, Ying-Cheng Chiang et al.[59] and Xavier et al.[17] demonstrated that CHI3L1 overexpression negatively affects the response of epithelial ovarian carcinoma cells to paclitaxel and pancreatic cancer cells to gemcitabine treatment, respectively.